Age (years) | Median | 58 | Â | Â |
---|---|---|---|---|
 | Range | 34–78 |  |  |
 | Patients |  | ||
ECOG performance status | Â | Â | Â | |
 0 |  |  | 15 | 58% |
 1 |  |  | 10 | 38% |
 2 |  |  | 1 | 4% |
Primary site: | Â | Â | Â | Â |
 Ovarian |  |  | 22 | 85% |
 Fallopian tube |  |  | 1 | 4% |
 Peritoneum |  |  | 3 | 11% |
Histology | Â | Â | Â | Â |
 Serous |  |  | 22 | 85% |
 Endometrioid |  |  | 1 | 4% |
 Endometrioid and clear cell |  |  | 1 | 4% |
 Other |  |  | 2 | 7% |
Differentiation | Â | Â | Â | Â |
 Grade 1 |  |  | - |  |
 Grade 2 |  |  | 1 | 4% |
 Grade 3 |  |  | 24 | 92% |
 Grade not assigned |  |  | 1 | 4% |
Tumor expression of mucin 1 by immunohistochemistry | ||||
 Positive |  |  | 23 | 88% |
 Negative |  |  | 2 | 8% |
 Not assessed |  |  | 1 | 4% |